DBCO-PEG9-DBCO se fragment [Multiple species] Morinidazole is a novel 5-nitroimidazole

Morinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation

NSC 95397(10 μM

Ferulic acid treatments significantly inhibit MMP-2 and MMP-9 expression stimulated by FGF1

only five or one mouse remained alive in the combination arm at the end of treatment or at the end of the study

PubMed PMID: 25450608

DBCO-PEG9-DBCO se fragment [Multiple species] Morinidazole is a novel 5-nitroimidazoleDBCO PEG9 DBCO is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2353409 50 2 Molecular Weight: 1031. 20 Formula: C58H70N4O13 Chemical Name: N,N' bis(3 {2 azatricyclo[10. 4. 0. 0,]hexadeca 1(16),4,6,8,12,14 hexaen 10 yn 2 yl} 3 oxopropyl) 4,7,10,13,16,19,22,25,28 nonaoxahentriacontanediamide Smiles: